Publications

treatment of clinically diagnosed laryngopharyngeal reflux disease.

to determine the incidence of helicobacter pylori (hp) stool antigen (hpsa) in patients with laryngopharyngeal reflux disease (lprd), and to make a comparison of 2 treatment regimens that have been used based on the presence or absence of hpsa positivity in patients with lprd.